{
  "ticker": "INDV",
  "company_name": "Indivior PLC",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT01738503",
      "title": "Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Opioid Related Disorder",
      "start_date": "2012-10",
      "completion_date": "2014-05",
      "enrollment": 0,
      "sponsor": "Indivior Inc."
    },
    {
      "nct_id": "NCT02510014",
      "title": "Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Opioid Use Disorder, Opioid-related Disorders",
      "start_date": "2015-07-27",
      "completion_date": "2017-01-31",
      "enrollment": 0,
      "sponsor": "Indivior Inc."
    },
    {
      "nct_id": "NCT02357901",
      "title": "Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Opioid Dependence, Opioid Related Disorders",
      "start_date": "2015-01-28",
      "completion_date": "2016-04-29",
      "enrollment": 0,
      "sponsor": "Indivior Inc."
    },
    {
      "nct_id": "NCT00725608",
      "title": "Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Opioid-Related Disorders, Opiate Dependence, Drug Abuse",
      "start_date": "2008-05",
      "completion_date": "2011-04",
      "enrollment": 0,
      "sponsor": "Indivior Inc."
    },
    {
      "nct_id": "NCT03002961",
      "title": "Single Ascending Dose Study of RBP-6000",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Opioid Use Disorder",
      "start_date": "2012-07",
      "completion_date": "2013-10",
      "enrollment": 0,
      "sponsor": "Indivior Inc."
    },
    {
      "nct_id": "NCT00723749",
      "title": "Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Opioid-Related Disorders, Opiate Dependence, Drug Abuse",
      "start_date": "2008-03",
      "completion_date": "2010-12",
      "enrollment": 0,
      "sponsor": "Indivior Inc."
    },
    {
      "nct_id": "NCT04995029",
      "title": "Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Moderate to Severe Opioid-use Disorder",
      "start_date": "2021-10-26",
      "completion_date": "2024-06-26",
      "enrollment": 0,
      "sponsor": "Indivior Inc."
    },
    {
      "nct_id": "NCT03978832",
      "title": "Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Schizophrenia",
      "start_date": "2019-06-28",
      "completion_date": "2020-05-12",
      "enrollment": 0,
      "sponsor": "Indivior Inc."
    },
    {
      "nct_id": "NCT04060654",
      "title": "SUBLOCADE Rapid Initiation Extension Study",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Opioid Use Disorder, Severe, Opioid Use Disorder, Moderate",
      "start_date": "2019-10-21",
      "completion_date": "2020-05-15",
      "enrollment": 0,
      "sponsor": "Indivior Inc."
    },
    {
      "nct_id": "NCT01846455",
      "title": "Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Hepatic Failure, Hepatic Impairment, Chronic Hepatitis C Infection With Hepatic Coma",
      "start_date": "2012-09",
      "completion_date": "2013-05",
      "enrollment": 0,
      "sponsor": "Indivior Inc."
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE2": 11,
      "PHASE3": 6,
      "": 9,
      "PHASE1": 10,
      "PHASE4": 11,
      "NA": 3
    },
    "by_status": {
      "COMPLETED": 46,
      "ACTIVE_NOT_RECRUITING": 1,
      "TERMINATED": 1,
      "UNKNOWN": 2
    },
    "active_trials": 1,
    "completed_trials": 46,
    "conditions": [
      "Alcohol Use Disorder",
      "Analgesic Response",
      "Buprenorphine, Naloxone, Opiate-related Disorders, Opiate Dependence, Drug Abuse",
      "Drug Addiction",
      "GERD",
      "Healthy",
      "Healthy Volunteer, Opioid-use Disorder",
      "Healthy Volunteers",
      "Healthy, Opioid Use",
      "Hepatic Failure, Hepatic Impairment, Chronic Hepatitis C Infection With Hepatic Coma",
      "Hepatitis C, Chronic",
      "Heroin Dependence",
      "Moderate to Severe Opioid Use Disorder",
      "Moderate to Severe Opioid-use Disorder",
      "Opiate Dependence",
      "Opiate Dependence, Drug Dependence",
      "Opiate-related Disorders, Opiate Dependence, Drug Abuse",
      "Opioid Dependence",
      "Opioid Dependence, Opioid Related Disorders",
      "Opioid Dependence, Opioid Related Disorders, Cocaine Dependence",
      "Opioid Dependency",
      "Opioid Overdose",
      "Opioid Related Disorder",
      "Opioid Use Disorder",
      "Opioid Use Disorder, Opioid-related Disorders",
      "Opioid Use Disorder, Severe, Opioid Use Disorder, Moderate",
      "Opioid-Related Disorders",
      "Opioid-Related Disorders, Opiate Dependence, Drug Abuse",
      "Opioid-Use Disorder, Opioid Overdose",
      "Opioid-related Disorders",
      "Opioid-use Disorder",
      "Opioid-use Disorder, Opioid-related Disorders",
      "Pain",
      "Schizophrenia"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:19:07.132061",
    "search_query": "Indivior PLC",
    "url": "https://clinicaltrials.gov/search?term=Indivior+PLC"
  }
}